PortViewPortView
IDNA logo

iShares Genomics Immunology and Healthcare (IDNA) ETF Holdings & Analysis

ETFOther

$39.67
1-year price historyRange $22.46 – $41.48

What IDNA does

The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.

Fund profile

Category
Other
AUM
$186.01M
Holdings
10

Top holdings

Top 1045%
HoldingWeight
MODERNA8.69%
TWIST BIOSCIENCE6.10%
REVOLUTION MEDICINES4.16%
GENMAB4.06%
BAYER AG4.04%
REGENERON PHARMACEUTICALS3.73%
MERCK & CO INC3.67%
INCYTE CORP3.63%
VERTEX PHARMACEUTICALS3.62%
TAKEDA PHARMACEUTICAL3.52%

Sector allocation

Healthcare100.00%

Geographic allocation

United States63.60%
Germany7.49%
France6.56%
Japan5.14%
Switzerland4.78%
Denmark4.02%
United Kingdom2.92%
Canada2.50%
China2.00%
Luxembourg0.52%

PortView Portfolio Insights

PortView analyzes how IDNA fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IDNA in PortView →

Related securities

Related stocks

Frequently asked questions

What does IDNA track?
IDNA is the iShares Genomics Immunology and Healthcare ETF, a Other ETF.
What is the expense ratio of IDNA?
Expense ratio data for IDNA is shown on the page when available from our data provider.
What are the largest holdings in IDNA?
Top holdings include MRNA, TWST, RVMD, GMAB.CO, BAYN.DE.
How can PortView analyze IDNA overlap with other ETFs?
PortView computes the holdings overlap between IDNA and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.